Eli Lilly and Company News - April 5, 2026

Lilly's New Obesity Pill Launches Tomorrow — But Can It Justify a $935 Stock Price in a Price War With Novo?

Shares shifted as Eli Lilly secured FDA approval on April 1 for its once-daily weight-loss pill, the first oral obesity drug patients can take at any time...

Eli Lilly Wins FDA Approval for Foundayo, a Flexible Obesity Pill

The FDA approved Eli Lilly’s once-daily weight-loss pill, Foundayo (orforglipron), on April 1, 2026. This drug is the first oral GLP-1 for weight management...